Article Details
Retrieved on: 2024-02-05 01:05:45
Tags for this article:
Click the tags to see associated articles and topics
Summary
Bioxyne Limited's subsidiary, Breathe Life Sciences, is the first in Australia to receive a GMP license for producing medical cannabis, MDMA, and psilocybin, targeting mental health treatments. This move facilitates innovative therapies and positions Bioxyne as a leader in alternative medicine manufacturing.
Article found on: www.australianmanufacturing.com.au
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here